Tumor burden as an independent prognostic factor in metastatic renal cell carcinoma (mRCC).

被引：0
作者：
Escudier, Bernard J.
Iacovelli, Roberto
Lanoy, Emilie
Albiges, Laurence
Fizazi, Karim
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Univ Roma La Sapienza, Deparment Radiol Oncol & Human Pathol, Oncol Unit, I-00185 Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.397
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
397
引用
收藏
页数：1
相关论文
共 50 条
[31]   Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma [J].
Jeppesen, A. N. ;
Jensen, H. K. ;
Donskov, F. ;
Marcussen, N. ;
von der Maase, H. .
BRITISH JOURNAL OF CANCER, 2010, 102 (05) :867-872
[32]   External validation of a sunitinib prognostic nomogram in patients (pts) with metastatic renal cell carcinoma (mRCC). [J].
Yu, Changhong ;
Kattan, Michael W. ;
Hutson, Thomas E. ;
Hudes, Gary R. ;
Yuan, Jinyu ;
Valota, Olga ;
Motzer, Robert John .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[33]   Preoperative apolipoprotein B/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma [J].
Zhang, Fan ;
Xie, Yongpeng ;
Ma, Xin ;
Gu, Liangyou ;
Li, Hongzhao ;
Li, Xintao ;
Guo, Gang ;
Zhang, Xu .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (03) :184.e9-184.e17
[34]   Metastatic renal cell carcinoma (MRCC): Responses to different immunotherapies [J].
Landonio, G ;
Baiocchi, C ;
Ferrari, M ;
Gottardi, O ;
Majno, M ;
Scanzi, F .
EUROPEAN JOURNAL OF CANCER, 1995, 31A :468-468
[35]   Expression of VHL and SRC in metastatic renal cell carcinoma (mRCC). [J].
Luo, Jia ;
Podolak, Jennifer ;
Degnin, Catherine ;
Chen, Yiyi ;
Robinson, Kyle William ;
Pukay, Marina ;
Schilling, Amy ;
Poage, Cara ;
Thomas, George V. ;
Ryan, Christopher W. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[36]   Biological toxicity as a predictive factor of efficacy in metastatic renal cell carcinoma (mRCC) treated with sunitinib [J].
Guillabert, P. ;
Elaidi, R. T. ;
Teghom, C. ;
Medioni, J. .
EUROPEAN JOURNAL OF CANCER, 2013, 49 :S651-S651
[37]   Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma [J].
Suppiah, Revathi ;
Shaheen, Philip E. ;
Elson, Paul ;
Misbah, Seema A. ;
Wood, Laura ;
Motzer, Robert J. ;
Negrier, Slyvie ;
Andresen, Steven W. ;
Bukowski, Ronald M. .
CANCER, 2006, 107 (08) :1793-1800
[38]   Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma [J].
Kwak, Cheol ;
Park, Yong Hyun ;
Jeong, Chang Wook ;
Jeong, Hyeon ;
Lee, Sang Eun ;
Moon, Kyung Chul ;
Ku, Ja Hyeon .
JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (04) :317-323
[39]   Characteristics of metastasis as a prognostic factor for immunotherapy in metastatic renal cell carcinoma [J].
Kwak, Cheol ;
Park, Yong Hyun ;
Jeong, Chang Wook ;
Jeong, Hyeon ;
Lee, Sang Eun ;
Ku, Ja Hyeon .
TUMORI JOURNAL, 2007, 93 (01) :68-74
[40]   Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma [J].
Tsimafeyeu, Ilya V. ;
Demidov, Lev V. ;
Madzhuga, Albina V. ;
Somonova, Oksana V. ;
Yelizarova, Anna L. .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
12345